American Heart Month serves as a reminder for health care providers to not only provide the best care possible to their patients but also prioritize their own health.
Over the past 2 years, we have been surrounded by an overwhelming
amount of information about the COVID-19 pandemic. From vaccines
to the development of new variants, it’s easy to get caught up in the
moment and forget there are other aspects of our health we need to take care
of, such as our heart.
February is American Heart Month, and according to the Centers for
Disease Control and Prevention, 1 in every 5 female deaths in the United
States is from heart disease, which is the leading cause of death of US
women.1 Additionally, cardiovascular disease accounted for the highest
percentage of total deaths for all subgroups of women in 2018, according
to the American Heart Association.2
American Heart Month serves as a reminder for health care providers
to not only provide the best care possible to their patients but also
prioritize their own health. It can be easy to forget to care for yourself
both physically and mentally, especially during a pandemic. Some heart-healthy tips to reduce your risk of heart disease include limiting your
alcohol consumption, managing your stress levels, making healthy food
choices, and if you smoke, quitting smoking.1
For our February issue, Contemporary OB/GYN hopes to bring back the focus on heart health with a featured peer-reviewed article on statin use in midlife women. This comprehensive article tackles risk assessment of cardiovascular disease in women and provides tips on lifestyle counseling, medication management, and the adverse effects of using statins to help physicians provide optimal care to their patients and their own heart health.
Mike Hennessy Jr
President and CEO, MJH Life Sciences
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More